Skip to main content
Kexing Biopharm logo

Kexing Biopharm — Investor Relations & Filings

Ticker · 688136 ISIN · CNE100006ZG6 LEI · 529900Z34Q1M9A907771 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 754 across all filing types
Latest filing 2023-12-29 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688136

About Kexing Biopharm

https://www.kexingbiopharm.com/

Kexing Biopharm is an innovative biopharmaceutical enterprise engaged in the research, development, production, and sales of recombinant protein drugs and micro-ecological preparations. The company focuses on developing treatments for therapeutic areas including kidney diseases, oncology, antiviral therapy, autoimmune disorders, metabolic diseases, and degenerative diseases. A key product in its portfolio is Erythropoietin Injection. Kexing Biopharm maintains a comprehensive quality system that aligns with international standards, covering the entire drug lifecycle from production and quality control to release and transportation, ensuring the continuous and stable manufacturing of safe and effective medicines.

Recent filings

Filing Released Lang Actions
关于公司2024年度日常关联交易额度预计的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the company's expected daily related-party transactions for the year 2024. It includes information about the board meeting approvals, independent director opinions, audit committee opinions, supervisory board resolutions, detailed transaction amounts, related parties' background, contract terms, and the impact of these transactions on the company. The document is a formal disclosure typically required by stock exchanges for related-party transactions. It is not a financial report like an annual or interim report, nor is it a management discussion or earnings release. It is also not a proxy statement or voting result announcement. The document is a regulatory announcement about related-party transactions, which fits best under Regulatory Filings (RNS) as it is a compliance disclosure and does not fit other more specific categories. The document length (5932 characters) and content confirm it is a full announcement, not just a brief notice or report publication announcement. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2023-12-29 Chinese
关于公司2024年度对外担保额度预计的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding its expected external guarantee limit for the year 2024. It details the guarantee amount, the parties involved, the board's approval process, and the rationale behind the guarantee. The document is relatively short (3031 characters) and focuses on a specific financial arrangement (external guarantees) rather than presenting comprehensive financial statements or full financial performance data. It is not an annual or interim report, nor is it a call transcript or audit report. It is also not a report publication announcement since it contains substantive information about the guarantee. The document fits best into the category of Capital/Financing Update (CAP), as it relates to financing activities and guarantees provided by the company for its subsidiaries' bank loans.
2023-12-29 Chinese
关于制定公司部分治理制度的公告
Governance Information Classification · 95% confidence The document is a company announcement regarding the establishment of certain governance systems, specifically mentioning the adoption of new governance rules and referencing compliance with company law and stock exchange regulations. It is issued by the board of directors and relates to governance structure improvements. The document is short (486 characters) and does not contain financial data or detailed report content. It is not an annual report, audit report, or financial statement. It is not a voting result or dividend announcement. The content fits the category of Governance Information, which covers reports detailing the company's internal rules, board structure, and governance practices.
2023-12-29 Chinese
关于公司2024年向银行等金融机构申请融资额度的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company about its plan to apply for a new financing credit line from banks and financial institutions. It details the amount, purpose, and collateral for the financing. There are no financial statements, no detailed financial performance data, no audit information, nor is it a report or transcript. The document is a formal announcement about capital raising activities, specifically about financing limits and related authorizations. This fits the definition of a Capital/Financing Update (CAP). The document length is short and it is not merely announcing the publication of a report, so it is not an RPA. Therefore, the classification is CAP with high confidence.
2023-12-29 Chinese
关于控股股东及实际控制人自愿承诺特定期间不减持公司股份的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement from a company disclosing a voluntary commitment by its controlling shareholder and actual controller not to reduce their shareholding within a specified period. It includes details about the shareholders' holdings and the commitment period. There is no financial data, no report attached or referenced as being published, and no mention of a meeting or voting results. The content fits the category of a Major Shareholding Notification, as it concerns shareholding levels and commitments related to shares held by major shareholders.
2023-12-06 Chinese
中信建投证券股份有限公司关于科兴生物制药股份有限公司首次公开发行部分限售股上市流通的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from a sponsoring institution regarding the listing and circulation of restricted shares from a company's initial public offering (IPO) on the STAR Market. It includes specifics about the number of shares, lock-up periods, shareholder commitments, changes in share capital, and compliance with regulatory requirements. The document is not a full annual or interim financial report, nor is it a simple announcement. It is a formal audit or verification report related to the IPO share lock-up release, which fits the category of an Audit Report / Information (AR). The document length is 3118 characters, which is relatively short but contains substantive verification content rather than just an announcement or certification. Therefore, the best classification is AR with high confidence. FY 2023
2023-12-06 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.